Murphy Capital Management’s GSK GSK Stock Holding History

Murphy Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,940	Closed	-$205K	–	250
2019 Q1	$205K	Buy	+3,940	New	+$197K	0.03%	236
2018 Q4	–	Sell	-4,540	Closed	-$227K	–	245
2018 Q3	$227K	Sell	4,540 -380	-8%	-$19.3K	0.03%	247
2018 Q2	$247K	Sell	4,920 -40	-0.8%	-$2.02K	0.04%	244
2018 Q1	$242K	Sell	4,960 -200	-4%	-$9.31K	0.03%	236
2017 Q4	$228K	Buy	5,160 +1,000	+24%	+$46.2K	0.03%	242
2017 Q3	$211K	Sell	4,160 -320	-7%	-$16.2K	0.03%	256
2017 Q2	$241K	Hold	4,480	–	–	0.04%	239
2017 Q1	$236K	Buy	4,480 +240	+6%	+$12.2K	0.04%	252
2016 Q4	$204K	Buy	+4,240	New	+$209K	0.03%	263
2015 Q4	–	Sell	-4,414	Closed	-$212K	–	318
2015 Q3	$212K	Sell	4,414 -1,840	-29%	-$95.8K	0.04%	273
2015 Q2	$325K	Sell	6,254 -1,142	-15%	-$64.3K	0.05%	249
2015 Q1	$426K	Buy	7,396 +2	+0%	+$115	0.06%	225
2014 Q4	$395K	Sell	7,394 -1,494	-17%	-$83.6K	0.06%	233
2014 Q3	$510K	Buy	8,888 +242	+3%	+$14.8K	0.08%	203
2014 Q2	$577K	Sell	8,646 -548	-6%	-$37.1K	0.09%	195
2014 Q1	$614K	Buy	9,194 +963	+12%	+$65.1K	0.1%	188
2013 Q4	$549K	Sell	8,231 -158	-2%	-$10.2K	0.1%	196
2013 Q3	$526K	Buy	8,389 +135	+2%	+$8.69K	0.1%	184
2013 Q2	$515K	Buy	+8,254	New	+$524K	0.1%	179

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Murphy Capital Management's GSK Position: Q2 2019 in Review

Murphy Capital Management sold out of GSK (GSK) in Q2 2019, closing a stake of 3,940 shares — an estimated $205K sold.

Murphy Capital Management first reported a position in GSK in Q2 2013 and held it in 19 quarters. The position peaked at $614K in Q1 2014. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Murphy Capital Management reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Murphy Capital Management sold 3,940 GSK shares in Q2 2019, an estimated $205K.
Murphy Capital Management first reported a position in GSK in Q2 2013 and held it in 19 quarters.
Murphy Capital Management's GSK position peaked at $614K in Q1 2014.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Murphy Capital Management's 13F filing for Q2 2019, filed 22 Jul 2019.